FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

7272011000036103: Pegasys (peginterferon alfa-2a 180 microgram / 0.5 mL) injection, 0.5 mL syringe (trade product unit of use)

Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3097081000168114 Pegasys (peginterferon alfa-2a 180 microgram / 0.5 mL) injection, 0.5 mL syringe (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3097091000168112 Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe has manufactured dose form injection true Inferred relationship Some
Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe Is a trade product unit of use true Inferred relationship Some
Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe has manufactured dose form injection solution false Inferred relationship Some
Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe Is a peginterferon alfa-2a 180 microgram/0.5 mL injection, syringe true Inferred relationship Some
Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe Is a Pegasys true Inferred relationship Some
Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe has unit of use syringe true Inferred relationship Some 1412710469
Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe has intended active ingredient peginterferon alfa-2a true Inferred relationship Some 1412710468
Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe has Australian BoSS peginterferon alfa-2a true Inferred relationship Some 1412710468
Inbound Relationships Type Active Source Characteristic Refinability Group
Pegasys 180 microgram/0.5 mL injection, 4 x 0.5 mL syringes has TPUU True Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe Inferred relationship Some 1
Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (trade product pack) has TPUU True Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe Inferred relationship Some 2
Pegasys-RBV (4 x 180 microgram syringes, 140 x 200 mg tablets), 1 pack has TPUU True Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe Inferred relationship Some 1
Pegasys-RBV (4 x 180 microgram syringes, 168 x 200 mg tablets), 1 pack has TPUU True Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe Inferred relationship Some 2
Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [84 tablets], 1 pack (trade product pack) has TPUU True Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe Inferred relationship Some 2
Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [112 tablets], 1 pack (containered trade product pack) has TPUU True Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe Inferred relationship Some 1
Pegasys-RBV (4 x 180 microgram syringes, 140 x 200 mg tablets), 1 pack has TPUU True Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe Inferred relationship Some 1
Pegasys-RBV (peginterferon alfa-2a 180 microgram / 0.5 mL) injection [4 x 0.5 mL syringes] (&) (ribavirin 200 mg) tablet [84 tablets], 1 pack (containered trade product pack) has TPUU True Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe Inferred relationship Some 2
Pegasys 180 microgram/0.5 mL injection, 4 x 0.5 mL syringes has TPUU True Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe Inferred relationship Some 1
Pegasys-RBV (4 x 180 microgram syringes, 168 x 200 mg tablets), 1 pack has TPUU True Pegasys 180 microgram/0.5 mL injection, 0.5 mL syringe Inferred relationship Some 2

Reference Sets

Trade product unit of use reference set

Back to Start